Biogen Idec (BIIB) Reports FDA Approval of ALPROLIX
Tweet Send to a Friend
Biogen Idec (Nasdaq: BIIB) announced that the U.S. Food and Drug Administration (FDA) has approved ALPROLIX™ [Coagulation Factor IX (Recombinant) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE